Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

High Adherence Observed to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over 8 Years.

Barber CEH, Schieir O, Lacaille D, Marshall DA, Barnabe C, Hazlewood G, Thorne C, Ahluwalia V, Bartlett SJ, Boire G, Haraoui B, Hitchon CA, Keystone E, Tin D, Pope J, Denning L, Bykerk V; CATCH Investigators.

Arthritis Care Res (Hoboken). 2018 Feb 16. doi: 10.1002/acr.23439. [Epub ahead of print]

PMID:
29450976
2.

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.

Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Arthritis Care Res (Hoboken). 2018 Feb 13. doi: 10.1002/acr.23539. [Epub ahead of print]

PMID:
29438604
3.

Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Jan 11;51:71-78. doi: 10.1016/j.genhosppsych.2018.01.003. [Epub ahead of print]

PMID:
29353127
4.

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Marrie RA, Graff L, Walker JR, Fisk JD, Patten SB, Hitchon CA, Lix LM, Bolton J, Sareen J, Katz A, Berrigan LI, Marriott JJ, Singer A, El-Gabalawy R, Peschken CA, Zarychanski R, Bernstein CN.

JMIR Res Protoc. 2018 Jan 17;7(1):e15. doi: 10.2196/resprot.8794.

5.

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott JJ, Bernstein CN.

Mult Scler Relat Disord. 2017 Dec 16;20:9-15. doi: 10.1016/j.msard.2017.12.007. [Epub ahead of print]

6.

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

BMC Res Notes. 2017 Nov 25;10(1):619. doi: 10.1186/s13104-017-2958-1.

7.

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Epidemiol Psychiatr Sci. 2017 Nov 3:1-10. doi: 10.1017/S2045796017000579. [Epub ahead of print]

PMID:
29098977
8.

Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

J Psychosom Res. 2017 Oct;101:17-23. doi: 10.1016/j.jpsychores.2017.07.015. Epub 2017 Aug 1.

9.

Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.

Scally SW, Law SC, Ting YT, Heemst JV, Sokolove J, Deutsch AJ, Bridie Clemens E, Moustakas AK, Papadopoulos GK, van der Woude D, Smolik I, Hitchon CA, Robinson DB, Ferucci ED, Bernstein CN, Meng X, Anaparti V, Huizinga T, Kedzierska K, Reid HH, Raychaudhuri S, Toes RE, Rossjohn J, El-Gabalawy H, Thomas R.

Ann Rheum Dis. 2017 Nov;76(11):1915-1923. doi: 10.1136/annrheumdis-2017-211300. Epub 2017 Aug 11.

PMID:
28801345
10.

Markedly increased incidence of critical illness in adults with Type 1 diabetes.

Marrie RA, Sellers EAC, Chen H, Fransoo R, Bernstein CN, Hitchon CA, Peschken CA, Garland A.

Diabet Med. 2017 Oct;34(10):1414-1420. doi: 10.1111/dme.13404. Epub 2017 Jul 12.

PMID:
28626956
11.

Hospitalization is associated with subsequent disability in multiple sclerosis.

Garland A, Metz LM, Bernstein CN, Peschken CA, Hitchon CA, Marrie RA.

Mult Scler Relat Disord. 2017 May;14:23-28. doi: 10.1016/j.msard.2017.03.009. Epub 2017 Mar 24.

12.

Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.

Marrie RA, Hitchon CA, Peschken CA, Chen H, Bernstein CN, Garland A.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):975-982. Epub 2017 Jun 5.

PMID:
28598781
13.

Increased Incidence of Critical Illness in Psoriasis.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Garland A.

J Cutan Med Surg. 2017 Sep/Oct;21(5):395-400. doi: 10.1177/1203475417712497. Epub 2017 Jun 6.

PMID:
28587481
14.

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis.

Fiest KM, Hitchon CA, Bernstein CN, Peschken CA, Walker JR, Graff LA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

J Clin Rheumatol. 2017 Dec;23(8):425-434. doi: 10.1097/RHU.0000000000000489.

15.

Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Litster B, Fiest KM, Patten SB, Fisk JD, Walker JR, Graff LA, Bolton JM, Sareen J, Marriott JJ, Berrigan LI, Bernstein CN, Zarychanski R, Singer A, Hitchon CA, Peschken CA, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

Int J MS Care. 2016 Nov-Dec;18(6):273-281. doi: 10.7224/1537-2073.2016-004.

16.

Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.

Meng X, Ezzati P, Smolik I, Bernstein CN, Hitchon CA, El-Gabalawy HS.

PLoS One. 2016 Oct 27;11(10):e0165501. doi: 10.1371/journal.pone.0165501. eCollection 2016.

17.

Reply.

Hitchon CA, Koppejan H, Trouw LA, Huizinga TJ, Toes RE, El-Gabalawy HS.

Arthritis Rheumatol. 2016 Nov;68(11):2826-2827. doi: 10.1002/art.39831. Epub 2016 Oct 9. No abstract available.

18.

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.

Fiest KM, Bernstein CN, Walker JR, Graff LA, Hitchon CA, Peschken CA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Singer A, Marrie RA; CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”.

BMC Res Notes. 2016 Aug 12;9(1):404. doi: 10.1186/s13104-016-2204-2. Review.

19.

Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.

Hitchon CA, Boire G, Haraoui B, Keystone E, Pope J, Jamal S, Tin D, Thorne C, Bykerk VP; CATCH investigators.

Rheumatology (Oxford). 2016 Oct;55(10):1751-62. doi: 10.1093/rheumatology/kew061. Epub 2016 Jun 21.

PMID:
27330161
20.

Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.

Koppejan H, Trouw LA, Sokolove J, Lahey LJ, Huizinga TJ, Smolik IA, Robinson DB, El-Gabalawy HS, Toes RE, Hitchon CA.

Arthritis Rheumatol. 2016 Sep;68(9):2090-8. doi: 10.1002/art.39664.

21.

High rates of obesity and greater associated disability among people with rheumatoid arthritis in Canada.

Colmegna I, Hitchon CA, Bardales MC, Puri L, Bartlett SJ.

Clin Rheumatol. 2016 Feb;35(2):457-60. doi: 10.1007/s10067-015-3154-0. Epub 2015 Dec 28.

PMID:
26712499
22.

A Population-based Study of Intensive Care Unit Admissions in Rheumatoid Arthritis.

Peschken CA, Hitchon CA, Garland A, Bernstein CN, Chen H, Fransoo R, Marrie RA.

J Rheumatol. 2016 Jan;43(1):26-33. doi: 10.3899/jrheum.150312. Epub 2015 Dec 1.

23.

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH).

Barnabe C, Sun Y, Boire G, Hitchon CA, Haraoui B, Thorne JC, Tin D, van der Heijde D, Curtis JR, Jamal S, Pope JE, Keystone EC, Bartlett S, Bykerk VP; CATCH Investigators.

PLoS One. 2015 Aug 24;10(8):e0135327. doi: 10.1371/journal.pone.0135327. eCollection 2015.

24.

Health care utilization before and after intensive care unit admission in multiple sclerosis.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A.

Mult Scler Relat Disord. 2015 Jul;4(4):296-303. doi: 10.1016/j.msard.2015.05.010. Epub 2015 May 30.

25.

Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.

Bernstein CN, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, Marrie RA.

Inflamm Bowel Dis. 2015 Jun;21(6):1341-7. doi: 10.1097/MIB.0000000000000363.

26.

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.

Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, Boire G, Thorne JC, Tin D, Hitchon CA, Bingham CO 3rd, Bykerk VP.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1345-53. doi: 10.1002/acr.22606.

27.

The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.

Hazlewood GS, Thorne JC, Pope JE, Lin D, Tin D, Boire G, Haraoui B, Hitchon CA, Keystone EC, Jamal S, Bykerk VP; CATCH Investigators.

Ann Rheum Dis. 2016 Jun;75(6):1003-8. doi: 10.1136/annrheumdis-2014-206504. Epub 2015 May 15.

PMID:
25979945
28.

Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort.

Yang G, Bykerk VP, Boire G, Hitchon CA, Thorne JC, Tin D, Haraoui B, Keystone EC, Pope JE; CATCH Investigators.

J Rheumatol. 2015 Jan;42(1):46-54. doi: 10.3899/jrheum.131382. Epub 2014 Nov 15.

PMID:
25399388
29.

Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort.

Wong LE, Huang WT, Pope JE, Haraoui B, Boire G, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP; Canadian Early Arthritis Cohort Investigators.

Arthritis Care Res (Hoboken). 2015 May;67(5):616-23. doi: 10.1002/acr.22494.

30.

Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A.

Neurology. 2014 Jun 10;82(23):2112-9. doi: 10.1212/WNL.0000000000000495. Epub 2014 May 7.

31.

Increased incidence of critical illness among patients with inflammatory bowel disease: a population-based study.

Marrie RA, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, Bernstein CN.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2063-70.e1-4. doi: 10.1016/j.cgh.2014.03.033. Epub 2014 Apr 12.

PMID:
24726908
32.

Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort.

Harris JA, Bykerk VP, Hitchon CA, Keystone EC, Thorne JC, Boire G, Haraoui B, Hazlewood G, Bonner AJ, Pope JE; CATCH Investigators.

J Rheumatol. 2013 Nov;40(11):1823-30. doi: 10.3899/jrheum.121316. Epub 2013 Sep 15.

PMID:
24037554
33.

Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.

Barra L, Bykerk V, Pope JE, Haraoui BP, Hitchon CA, Thorne JC, Keystone EC, Boire G; Catch Investigators.

J Rheumatol. 2013 Aug;40(8):1259-67. doi: 10.3899/jrheum.120736. Epub 2013 Feb 1.

PMID:
23378461
34.

Pregnancy and the risk of rheumatoid arthritis in a highly predisposed North American Native population.

Peschken CA, Robinson DB, Hitchon CA, Smolik I, Hart D, Bernstein CN, El-Gabalawy HS.

J Rheumatol. 2012 Dec;39(12):2253-60. doi: 10.3899/jrheum.120269. Epub 2012 Oct 15.

PMID:
23070994
35.

Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.

Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, Sholter DE, Khraishi M, Haraoui B, Chen H, Li X, Laupacis A, Boire G, Tomlinson G, Bombardier C.

J Rheumatol. 2012 Nov;39(11):2088-97. doi: 10.3899/jrheum.120100. Epub 2012 Aug 15.

PMID:
22896027
36.

The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity.

Bykerk VP, Jamal S, Boire G, Hitchon CA, Haraoui B, Pope JE, Thorne JC, Sun Y, Keystone EC.

J Rheumatol. 2012 Nov;39(11):2071-80. doi: 10.3899/jrheum.120029. Epub 2012 Aug 15.

PMID:
22896026
37.

Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives.

Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA, El-Gabalawy HS.

J Rheumatol. 2012 Sep;39(9):1792-7. doi: 10.3899/jrheum.120387. Epub 2012 Aug 1.

PMID:
22859341
38.

Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.

Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP.

Ann Rheum Dis. 2013 Jun;72(6):949-54. doi: 10.1136/annrheumdis-2012-201506. Epub 2012 Jul 11.

39.

Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.

McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE; CATCH Investigators.

Rheumatology (Oxford). 2012 Sep;51(9):1662-9. Epub 2012 Apr 25.

PMID:
22539481
40.

Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.

El-Gabalawy HS, Robinson DB, Smolik I, Hart D, Elias B, Wong K, Peschken CA, Hitchon CA, Li X, Bernstein CN, Newkirk MM, Fritzler MJ.

Arthritis Rheum. 2012 Jun;64(6):1720-9. doi: 10.1002/art.34449. Epub 2012 Feb 21.

41.

The synovium in rheumatoid arthritis.

Hitchon CA, El-Gabalawy HS.

Open Rheumatol J. 2011;5:107-14. doi: 10.2174/1874312901105010107. Epub 2011 Dec 30.

42.

Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort.

Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, Sholter DE, Khraishi M, Haraoui B, Chen H, Li X, Laupacis A, Boire G, Tomlinson G, Bombardier C.

J Rheumatol. 2011 Nov;38(11):2342-5. doi: 10.3899/jrheum.110249. Epub 2011 Sep 1.

PMID:
21885485
43.

Infection and rheumatoid arthritis: still an open question.

Hitchon CA, El-Gabalawy HS.

Curr Opin Rheumatol. 2011 Jul;23(4):352-7. doi: 10.1097/BOR.0b013e3283477b7b. Review.

PMID:
21532483
44.

Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®).

Cheng CK, McDonald-Blumer H, Boire G, Pope JE, Haraoui B, Hitchon CA, Thorne C, Sun Y, Bykerk VP.

J Rheumatol. 2010 Nov;37(11):2221-5. doi: 10.3899/jrheum.091368. Epub 2010 Aug 17.

PMID:
20716658
45.

Rheumatoid arthritis in a north american native population: longitudinal followup and comparison with a white population.

Peschken CA, Hitchon CA, Robinson DB, Smolik I, Barnabe CR, Prematilake S, El-Gabalawy HS.

J Rheumatol. 2010 Aug 1;37(8):1589-95. doi: 10.3899/jrheum.091452. Epub 2010 Jun 15.

PMID:
20551109
46.

Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.

Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, Markland J, Robinson D, Elias B, Newkirk M, Toes RM, Huizinga TW, El-Gabalawy HS.

J Rheumatol. 2010 Jun;37(6):1105-12. doi: 10.3899/jrheum.091323. Epub 2010 May 1.

PMID:
20436074
47.

Clinical and serologic factors associated with lupus pleuritis.

Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, Tucker LB, Petty RE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS), Peschken CA.

J Rheumatol. 2010 Apr;37(4):747-53. doi: 10.3899/jrheum.090249. Epub 2010 Jan 28.

PMID:
20110526
48.

Characterization of synovial tissue from arthritis patients: a proton magnetic resonance spectroscopic investigation.

Hitchon CA, El-Gabalawy HS, Bezabeh T.

Rheumatol Int. 2009 Aug;29(10):1205-11. doi: 10.1007/s00296-009-0865-z. Epub 2009 Jan 28.

PMID:
19184029
49.

Sm antibodies increase risk of death in systemic lupus erythematosus.

Hitchon CA, Peschken CA.

Lupus. 2007;16(3):186-94.

PMID:
17432104
50.

Hyaluronate effects on synovium and synovial fluid. A prospective blinded study in patients with osteoarthritis of the knee.

Schumacher HR, Paul C, Hitchon CA, El-Gabalawy H, Zonay L, Clayburne G, Sieck M, Schwab E.

Osteoarthritis Cartilage. 2006 May;14(5):501-3. Epub 2006 Jan 20. No abstract available.

Supplemental Content

Loading ...
Support Center